ADVFN - Advanced Financial Network.
HOME» NYSE » C » CAH Stock Price » CAH Stock News

Cardinal Health Share News

 Cardinal Health, Inc. Stock Price
CAH Stock Price
 Cardinal Health, Inc. Stock Chart
CAH Stock Chart
 Cardinal Health, Inc. Stock News
CAH Stock News
 Cardinal Health, Inc. Company Information
CAH Company Information
 Cardinal Health, Inc. Stock Trades
CAH Stock Trades

Cardinal Health Names Former J&J Executive To Lead Medical Products Operations

DOW JONES NEWSWIRES Cardinal Health Inc. (CAH) has appointed a former Johnson & Johnson (JNJ) executive to lead its $9 billion medical products and services business as the health-care company seeks to diversify its businesses. Donald M. Casey, 52, formerly led Johnson & Johnson's worldwide comprehensive care group before becoming CEO of a non-profit research institute aimed at finding low-cost technological health-care solutions. "His track record of commercializing innovation, deep operational expertise and outstanding strategic leadership will be tremendous assets as we continue to grow our core businesses and expand our footprint," said Chief Executive George S. Barrett. Casey will report to Barrett, starting April 16. Cardinal Health, the second-biggest drug distributor in the U.S., has reported stronger revenue lately amid a string of acquisitions, as it seeks to reduce its dependence on major customers like CVS Caremark Corp. (CVS) and drug-store chain Walgreen Co. (WAG). Its medical business, which provides medical and surgical products and services to hospitals, doctors' offices and other health care providers, is the smaller of Cardinal Health's core businesses. The segment reported a 9.4% revenue increase in the second quarter, but an 18% drop in profits on commodity price pressure and investment costs. Casey was most recently the first CEO of the non-profit Gary and Mary West Wireless Health Institute, a research organization that seeks to lower the cost of health care through technological solutions. Casey will remain on the Institute's board of directors. Casey also spent 24 years at Johnson & Johnson (JNJ), most recently leading its $10 billion comprehensive care group, which includes cardiovascular, diagnostic, diabetes and vision franchises. The former head of the medical business, Mike Lynch, 51, is leaving in order to head his own company in the Chicago area. Shares closed at $41.63 on Monday and were inactive premarket. The stock is up 2.5% so far this year. -By Kristin Jones; Dow Jones Newswires; 212-416-2208; kristin.jones@dowjones.com

Stock News for Cardinal Health (CAH)
DateTimeHeadline
03/26/201503:20:53Top Large Cap Stocks That Investors Can Buy Now
03/25/201510:20:00The Time Is Now To Fully Measure ROI Of Medication Therapy Management
03/17/201507:56:35The Best Stocks To Buy This Week
03/09/201505:48:27The Top Scoring Stocks To Buy This Week
03/04/201516:52:44Statement of Changes in Beneficial Ownership (4)
03/04/201516:52:16Statement of Changes in Beneficial Ownership (4)
03/04/201516:52:16Statement of Changes in Beneficial Ownership (4)
03/03/201508:30:00Cardinal Health Named One of the "Top 50 Companies for Executive...
03/02/201515:28:06Cardinal Health to Buy J&J's Heart Business -- 2nd Update
03/02/201511:53:23Cardinal Health to Buy J&J's Heart Business -- Update
03/02/201508:55:40J & J jettisons Cordis for ~$2B
03/02/201508:31:19Cardinal Health to Buy J&J's Heart Business
03/02/201507:38:19Current Report Filing (8-k)
03/02/201507:30:00Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac...
03/02/201507:30:00Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac...
03/01/201504:33:35The Best Scoring Stocks To Buy Now
02/23/201517:01:59Statement of Changes in Beneficial Ownership (4)
02/23/201516:18:54J & J rumored to have found a buyer for Cordis unit
02/12/201510:40:06Schedule 13g<br /> (sc 13g/a)
02/11/201517:27:27Statement of Ownership (sc 13g)

Cardinal Health and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad